Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (1084)	7/24/1998 5:10:00 PM
From: David Cathcart	Read Replies (1) \| Respond to of 1826

Richard, To my knowledge, each phase II trial for each tumor type is separate and distinct. It can succeed or fail on its own without effecting the phase II trials for other tumor types. As such, I would expect the company to release information as each separate phase II trial completes. I don't know how long each individual phase II trial typically takes. Anyone?? Supposedly, phase II for Taxol went very quickly due to relatively strong efficacy results. Let's expect good news in six months. Enjoy the weekend. David